Abstract
The majority of pituitary adenomas associated with MEN 1 secrete prolactin or growth hormone. For both types, medical treatment is an acceptable option, particularly for prolactinomas. A significant number of patients with this syndrome will, however, require surgery because of ineffectiveness of medical therapy or compression or invasion of parasellar structures. This article discusses current strategies for the medical and surgical management of prolactinomas and of acromegaly, with special attention to the diagnostic and therapeutic pitfalls associated with MEN 1.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Endocrinology and Metabolism Clinics of North America
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
